# The Effects of Bimodal tDCS on Illness Severity, Insight, Functional Outcomes, Neurocognition and HRV in Schizophrenia

> **NCT03701100** · NA · COMPLETED · sponsor: **Tri-Service General Hospital** · enrollment: 60 (actual)

## Conditions studied

- Schizophrenia
- Insight Impaired
- Psychotic Symptoms
- Schizoaffective Disorder
- Neurocognitive Dysfunction
- Autonomic Imbalance
- Psychosocial Impairment
- Quality of Life

## Interventions

- **DEVICE:** tDCS

## Key facts

- **NCT ID:** NCT03701100
- **Lead sponsor:** Tri-Service General Hospital
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2017-07-17
- **Primary completion:** 2018-09-21
- **Final completion:** 2018-09-21
- **Target enrollment:** 60 (ACTUAL)
- **Last updated:** 2018-10-15


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03701100

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03701100, "The Effects of Bimodal tDCS on Illness Severity, Insight, Functional Outcomes, Neurocognition and HRV in Schizophrenia". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT03701100. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*